Bladder Cancer: Early Detection Crucial Amidst Higher Incidence in Poland

In Poland, bladder cancer presents a significant health challenge, ranking as the fourth most common cancer among men, a higher prevalence than the global sixth position. This statistic, while concerning, is partly explained by Poland's lower rates of alcohol-related and infection-associated cancers, which allows bladder cancer to feature more prominently in national statistics. The primary culprits behind this disease are well-established: smoking remains the leading risk factor, alongside occupational exposure to various chemicals prevalent in industries like petrochemicals, rubber, and paints. These occupational hazards disproportionately affect men, explaining the stark gender disparity in diagnosis, with women affected three to four times less frequently. Early detection is crucial, and the most critical warning sign is hematuria, or blood in the urine. Even a single, painless instance of blood in the urine warrants urgent medical attention. Unfortunately, patients often downplay this symptom, as it can be intermittent and painless, leading to delayed diagnosis and treatment. This lack of awareness and tendency to ignore early signs means that bladder cancer is often diagnosed at a more advanced stage in Poland compared to some Western European countries, despite improvements in oncological awareness and diagnostic pathways. Swift action upon noticing any blood in the urine is paramount for a better prognosis.

“

The most important of them is hematuria, that is, the presence of blood in the urine. It can appear very early and does not necessarily mean advanced disease. However, it is a symptom that everyone can observe. Importantly – even a single, painless hematuria, without other symptoms, is an alarm signal and requires urgent urological consultation.